POCI
PRECISION OPTICS CORPORATION, INC.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$4.27
−1.16%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 31.5M | 31.5M | 19.1M | 19.1M | 21.0M |
| Cost of Revenue | 26.1M | 26.1M | 15.7M | 13.3M | 13.3M |
| Gross Profit | 5.4M | 5.4M | 3.4M | 5.8M | 7.7M |
| Operating Expenses | |||||
| R&D Expense | 1.0M | 1.0M | 1.2M | 981.8K | 992.4K |
| SG&A Expense | 7.9M | 7.9M | 7.8M | 7.5M | 7.4M |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 8.9M | 8.9M | 9.0M | 8.5M | 8.4M |
| Cost and Expenses | 35.0M | 35.0M | 24.6M | 21.8M | 21.7M |
| Operating Income (EBIT) | (3.5M) | (3.5M) | (5.6M) | (2.7M) | (638.5K) |
| Non-Operating | |||||
| Interest Income | 31.8K | 31.8K | — | — | — |
| Interest Expense | 148.1K | 148.1K | 227.0K | 225.1K | 218.9K |
| Net Interest Income | (116.3K) | (116.3K) | (227.0K) | (225.1K) | (218.9K) |
| Other Non-Op Income/Expense | (116.3K) | (116.3K) | (227.0K) | (225.1K) | 495.9K |
| Non-Operating Income (excl Interest) | — | (31.8K) | — | — | (714.8K) |
| EBT (Pre-Tax Income) | (3.6M) | (3.6M) | (5.8M) | (2.9M) | (142.7K) |
| Income Tax Expense | 5.0K | 5.0K | 1.9K | 1.9K | 1.9K |
| Bottom Line | |||||
| Net Income | (3.6M) | (3.6M) | (5.8M) | (3.0M) | (144.6K) |
| Earnings from Cont. Ops | (3.6M) | (3.6M) | (5.8M) | (3.0M) | (144.6K) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (3.6M) | (3.6M) | (5.8M) | (3.0M) | (144.6K) |
| Per Share | |||||
| Basic EPS | ($0.46) | ($0.43) | ($0.85) | ($0.49) | ($0.03) |
| Diluted EPS | ($0.46) | ($0.43) | ($0.85) | ($0.49) | ($0.03) |
| Revenue Per Share | $3.70 | $3.70 | $2.81 | $3.15 | $3.71 |
| Shares | |||||
| Basic Shares Outstanding | 8.5M | 8.5M | 6.8M | 6.1M | 5.7M |
| Diluted Shares Outstanding | 8.5M | 8.5M | 6.8M | 6.1M | 5.7M |
| Profitability Metrics | |||||
| EBITDA | (3.2M) | (3.2M) | (5.3M) | (2.5M) | 287.0K |
| D&A | 279.3K | 279.3K | 212.4K | 212.4K | 210.7K |
| EBIT | (3.5M) | (3.5M) | (5.6M) | (2.7M) | 76.3K |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026